KV Pharmaceutical Co., a St. Louis drugmaker, agreed to improve its manufacturing processes to resolve a U.S. Food and Drug Administration lawsuit filed in the wake of a shutdown of the company’s production. “We have been working diligently with the ...
Tagged with: Catherine Hanaway David Van Vliet drugmaker KV Pharmaceutical Co. U.S. Food and Drug Administration
Read More »